Human P-glycoprotein differentially affects antidepressant drug transport: Relevance to blood-brain barrier permeability

Research output: Contribution to journalArticlepeer-review

Abstract

Abstract The pharmacological concept that inhibition of the drug efflux pump P-glycoprotein (P-gp) enhances brain distribution of the antidepressant imipramine in the rat has recently been demonstrated. To determine if these findings are relevant to humans, the present study investigated if imipramine is a transported substrate of human P-gp. Furthermore, additional experiments were carried out to determine if findings in relation to imipramine and human P-gp would apply to other antidepressants from a range of different classes. To this end, bidirectional transport experiments were carried out in the ABCB1-transfected MDCKII-MDR1 cell line. Transported substrates of human P-gp are subjected to net efflux in this system, exhibiting a transport ratio (TR) â

Original languageEnglish
Pages (from-to)2259-2272
Number of pages14
JournalInternational Journal of Neuropsychopharmacology
Volume16
Issue number10
DOIs
Publication statusPublished - Nov 2013

Keywords

  • Antidepressant
  • bidirectional transport study
  • imipramine
  • MDCKII-MDR1
  • P-glycoprotein

Fingerprint

Dive into the research topics of 'Human P-glycoprotein differentially affects antidepressant drug transport: Relevance to blood-brain barrier permeability'. Together they form a unique fingerprint.

Cite this